Francesca Fornari

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Nitric Oxide Synthase

Top Venues

Journal of hepatocellular carcinoma

Journal of experimental & clinical cancer research : CR

This page only lists publications with an associated author ORCID identifier.

Publications

Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Piscaglia Fabio, Claudio Stefanelli, Laura Gramantieri, Francesca Fornari
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response. Cancers 16 (4) (2024)
Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Piscaglia Fabio, Claudio Stefanelli, Laura Gramantieri, Francesca Fornari
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response. Cancers 16 (4) (2024)
Christian Bergamini, Ilaria Leoni, Nicola Rizzardi, Mattia Melli, Giuseppe Galvani, Camelia Alexandra Coada, Catia Giovannini, Elisa Monti, Irene Liparulo, Francesca Valenti, Manuela Ferracin, Matteo Ravaioli, Matteo Cescon, Francesco Vasuri, Fabio Piscaglia, Massimo Negrini, Claudio Stefanelli, Romana Fato, Laura Gramantieri, Francesca Fornari
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Catia Giovannini, Fabrizia Suzzi, Francesco Tovoli, Mariangela Bruccoleri, Mariarosaria Marseglia, Eleonora Alimenti, Francesca Fornari, Massimo Iavarone, Piscaglia Fabio, Laura Gramantieri
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular Carcinoma. Cancers 15 (6) (2023)
Catia Giovannini, Fabrizia Suzzi, Francesco Tovoli, Mariangela Bruccoleri, Mariarosaria Marseglia, Eleonora Alimenti, Francesca Fornari, Massimo Iavarone, Piscaglia Fabio, Laura Gramantieri
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular Carcinoma. Cancers 15 (6) (2023)
Laura Gramantieri, Francesca Fornari, Catia Giovannini, Davide Treré
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma. Biomolecules 12 (7) (2022)
Laura Gramantieri, Federica Gnudi, Francesco Vasuri, Daniele Mandrioli, Francesca Fornari, Francesco Tovoli, Fabrizia Suzzi, Andrea Vornoli, Antonia D'Errico, Piscaglia Fabio, Catia Giovannini
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area. Nutrients 14 (8) (2022)
Francesca Fornari, Catia Giovannini, Piscaglia Fabio, Laura Gramantieri
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research. Journal of hepatocellular carcinoma 9 (2022)
Francesca Fornari, Catia Giovannini, Piscaglia Fabio, Laura Gramantieri
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research. Journal of hepatocellular carcinoma 9 (2022)
Francesca Fornari, Catia Giovannini, Piscaglia Fabio, Laura Gramantieri
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions. Journal of hepatocellular carcinoma 8 (2021)
Catia Giovannini, Francesca Fornari, Piscaglia Fabio, Laura Gramantieri
Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs. Cells 10 (3) (2021)
Laura Gramantieri, Catia Giovannini, Piscaglia Fabio, Francesca Fornari
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 8 (2021)
Laura Gramantieri, Catia Giovannini, Fabrizia Suzzi, Ilaria Leoni, Francesca Fornari
Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers. Cancers 13 (18) (2021)
Catia Giovannini, Francesca Fornari, Valentina Indio, Davide Treré, Matteo Renzulli, Francesco Vasuri, Matteo Cescon, Matteo Ravaioli, Alessia Perrucci, Annalisa Astolfi, Fabio Piscaglia, Laura Gramantieri
Direct Antiviral Treatments for Hepatitis C Virus Have Off-Target Effects of Oncologic Relevance in Hepatocellular Carcinoma. Cancers 12 (9) (2020)
Stefano Cascinu, Giorgia Marisi, Vincenzo Dadduzio, Laura Gramantieri, Luca Faloppi, Paola Ulivi, Francesco Giuseppe Foschi, Emiliano Tamburini, Caterina Vivaldi, Mario Domenico Rizzato, Luca Ielasi, Matteo Canale, Fabio Conti, Britt Rudnas, Lorenzo Fornaro, Nicola Silvestris, Marianna Silletta, Giovanni Gerardo Cardellino, Sara Lonardi, Francesca Fornari, Giulia Orsi, Giulia Rovesti, Vittorina Zagonel, Stefano Cascinu, Mario Scartozzi
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (17) (2020)
Laura Gramantieri, Daniela Pollutri, Martina Gagliardi, Catia Giovannini, Santina Quarta, Manuela Ferracin, Andrea Casadei-Gardini, Elisa Callegari, Sabrina De Carolis, Sara Marinelli, Francesca Benevento, Francesco Vasuri, Matteo Ravaioli, Matteo Cescon, Piscaglia Fabio, Massimo Negrini, Luigi Bolondi, Francesca Fornari
MiR-30e-3p Influences Tumor Phenotype through MDM2/TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma. Cancer research 80 (8) (2020)
Ram C Shankaraiah, Laura Gramantieri, Francesca Fornari, Silvia Sabbioni, Elisa Callegari, Massimo Negrini
Animal Models of Hepatocellular Carcinoma Prevention. Cancers 11 (11) (2019)
Cristian Turato, Francesca Fornari, Daniela Pollutri, Matteo Fassan, Santina Quarta, Gianmarco Villano, Mariagrazia Ruvoletto, Luigi Bolondi, Laura Gramantieri, Patrizia Pontisso
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma. Journal of clinical medicine 8 (2) (2019)
Daniela Pollutri, Clarissa Patrizi, Sara Marinelli, Catia Giovannini, Elena Trombetta, Ferdinando A Giannone, Maurizio Baldassarre, Santina Quarta, Y P Vandewynckel, A Vandierendonck, H Van Vlierberghe, Laura Porretti, Massimo Negrini, Luigi Bolondi, Laura Gramantieri, Francesca Fornari
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma. Cell death & disease 9 (1) (2018)